Learn about Activase® (alteplase) treatment for acute ischemic stroke (AIS). See full safety for more information. Indications Activase (alteplase) is indicated for. Contraindications: Cathflo Activase should not be administered to patients with by a suture and lipid deposits or drug precipitates within the catheter lumen). Activase® (Alteplase) is a tissue plasminogen activator produced by recombinant .. A study of another alteplase product, Actilyse, in acute ischemic stroke, . mg vial—insert the spike end of an infusion set through the same puncture site.
|Country:||Moldova, Republic of|
|Published (Last):||25 June 2004|
|PDF File Size:||9.46 Mb|
|ePub File Size:||4.97 Mb|
|Price:||Free* [*Free Regsitration Required]|
Warnings Contraindications Acute Ischemic Stroke Do not administer to treat acute ischemic stroke in the following situations in which the risk of bleeding is greater than the potential benefit Current intracranial hemorrhage Subarachnoid hemorrhage Active internal bleeding Acitvase within 3 months intracranial or intraspinal surgery or serious head trauma Activase package insert of intracranial activase package insert that may increase the risk of bleeding eg, some neoplasms, arteriovenous malformations, aneurysms Bleeding diathesis Current severe uncontrolled hypertension.
The most frequent adverse reaction associated with all thrombolytics in all approved indications is bleeding. Recommended total dose for AMI is based activase package insert patient weight, not to exceed mg, regardless of the selected administration regimen accelerated activase package insert 3 hr. Open the package containing the transfer device by peeling the paper label off the package 4.
Contact the packkage plan provider for the most current information.
Single-Use Vial Lytic Thrombolytic – Cathflo® Activase® (alteplase)
You may also report side effects to Genentech at Sign Up It’s Free! Hypersensitivity, including urticaria, angioedema and anaphylaxis, reported in association with therapy; monitor patients during and for several hours after infusion for hypersensitivity; if signs of hypersensitivity occur, e. Tier Description 1 This drug is available at the lowest activase package insert.
Non-Medicare Plans Medicare Plans. Promotes thrombolysis by converting plasminogen to plasmin; plasmin degrades fibrin and fibrinogen. Positive evidence of human fetal risk. View explanations for tiers and restrictions.
FDA Internet Application Site (Accessdata) Error
Create Your List of Plans. All Interactions Sort By: Excessive pressure should be avoided when Cathflo Activase is instilled into the catheter. Mix by gently swirling until completely dissolved; complete dissolution occurs within 3 minutes; do NOT shake. activase package insert
Formulary Formulary Patient Discounts. Significant – Monitor Closely.
This restriction typically requires that certain criteria be met prior to approval for the prescription. Genentech will not contact the padkage you share content with.
The above information is provided for general informational and educational purposes only. Patients treated for acute ischemic stroke, with high risk of activase package insert hemorrhage, should be treated at facilities that can provide timely access to appropriate evaluation and management of intracranial hemorrhage.
Adverse Reactions In clinical trials, the most serious adverse pafkage reported after treatment were sepsis, gastrointestinal bleeding, and venous thrombosis. Submit the form below to share this with a friend or colleague. Controlled studies in pregnant women show no evidence of fetal risk.
Cathflo Activase should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Hypersensitivity Hypersensitivity, including urticaria, angioedema and anaphylaxis, has been reported in association with use of Cathflo Activase.
Quantity Limits Drugs that have quantity activase package insert associated with each prescription. Infections Cathflo Activase should be used with caution in the presence of known or suspected infection in the catheter.
Cathflo Activase should be used with caution in the presence of known or aactivase infection in the catheter. Internal bleeding intracranial, retroperitoneal, gastrointestinal, genitourinary, respiratory or external bleeding, especially at arterial and venous puncture sites may occur.
The activase package insert you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Lactation There are no data on presence of activase package insert in human milk, effects on inssrt infant, or on milk production. If arterial puncture necessary during therapy infusion, use upper extremity vessel that is accessible to manual compression, apply pressure for at least 30 min, and monitor puncture site closely.